The cruise ship of a GLP-1 plan is likely the right choice if: You are looking for sustainable, long-term weight loss that you can maintain
Another class of medications initially developed for the treatment of high blood glucose in patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2i), has also been demonstrated to reduce cardiovascular risk, with corresponding FDA product label changes and professional society recommendations endorsing their use
Sadaghian Sadabad M, von Martels JZ, Khan MT, Blokzijl T, Paglia G, Dijkstra G, et al
Molecules 28, 7444
Rounding from 8.3 to 8 units at the 2.5mg dose gives you 2.4mg, a 4% decrease
It noted that Wegovy wasnt launched until June 2021, the middle of the study period, and wasnt immediately covered by insurance